Which of the following anti-cancer drug comes under monoclonal antibodies: March 2013: (A) Di-ethyl-stilbestrol, (B) Tamoxifen, (C) Ritumixab, (D) Boezomib
Answer is C. Ans. C i.e. Ritumixab Rituximab It is a chimeric monoclonal antibody against the protein CD20, which is primarily found on the surface of B cells. Rituximab destroys B cells, and is therefore used to treat diseases which are characterized by excessive numbers of B cells, overactive B cells, or dysfunctional B cells. This includes many lymphomas, leukemias, transplant rejection, and autoimmune disorders.